Navigating uncertainties and evidence gaps in adjuvant therapy for premenopausal women with HR+/HER2- breast cancer

L. Licata, M. Mariani, A. Chiavassa, A.H. Partridge, C. Zanibelli, K. Jhaveri, K. Kalinsky, F. Patanè, C. Criscitiello, M. Lambertini, H.S. Rugo, M.M. Naldini, G. Notini, G. Viale, L. Pusztai, G. Bianchini

Open source

DOI
10.1016/j.annonc.2026.09.005
Published
2026-09
Container
Annals of Oncology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.annonc.2026.09.005,
  title = {Navigating uncertainties and evidence gaps in adjuvant therapy for premenopausal women with HR+/HER2- breast cancer},
  author = {L. Licata and M. Mariani and A. Chiavassa and A.H. Partridge and C. Zanibelli and K. Jhaveri and K. Kalinsky and F. Patanè and C. Criscitiello and M. Lambertini and H.S. Rugo and M.M. Naldini and G. Notini and G. Viale and L. Pusztai and G. Bianchini},
  year = {2026},
  journal = {Annals of Oncology},
  doi = {10.1016/j.annonc.2026.09.005},
  url = {https://doi.org/10.1016/j.annonc.2026.09.005}
}

RIS

TY  - JOUR
TI  - Navigating uncertainties and evidence gaps in adjuvant therapy for premenopausal women with HR+/HER2- breast cancer
AU  - L. Licata
AU  - M. Mariani
AU  - A. Chiavassa
AU  - A.H. Partridge
AU  - C. Zanibelli
AU  - K. Jhaveri
AU  - K. Kalinsky
AU  - F. Patanè
AU  - C. Criscitiello
AU  - M. Lambertini
AU  - H.S. Rugo
AU  - M.M. Naldini
AU  - G. Notini
AU  - G. Viale
AU  - L. Pusztai
AU  - G. Bianchini
PY  - 2026
JO  - Annals of Oncology
DO  - 10.1016/j.annonc.2026.09.005
UR  - https://doi.org/10.1016/j.annonc.2026.09.005
ER  - 

APA

Licata, L., Mariani, M., Chiavassa, A., Partridge, A., Zanibelli, C., Jhaveri, K., Kalinsky, K., Patanè, F., Criscitiello, C., Lambertini, M., Rugo, H., Naldini, M., Notini, G., Viale, G., Pusztai, L., & Bianchini, G. (2026). Navigating uncertainties and evidence gaps in adjuvant therapy for premenopausal women with HR+/HER2- breast cancer. Annals of Oncology. https://doi.org/10.1016/j.annonc.2026.09.005

Source records